These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 31152766)

  • 1. Multiple sclerosis: Possibility of a gut environment-induced disease.
    Sato W; Yamamura T
    Neurochem Int; 2019 Nov; 130():104475. PubMed ID: 31152766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives.
    Chu F; Shi M; Lang Y; Shen D; Jin T; Zhu J; Cui L
    Mediators Inflamm; 2018; 2018():8168717. PubMed ID: 29805314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis.
    Calvo-Barreiro L; Eixarch H; Montalban X; Espejo C
    Autoimmun Rev; 2018 Feb; 17(2):165-174. PubMed ID: 29191793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood.
    Yadav SK; Boppana S; Ito N; Mindur JE; Mathay MT; Patel A; Dhib-Jalbut S; Ito K
    Proc Natl Acad Sci U S A; 2017 Oct; 114(44):E9318-E9327. PubMed ID: 29078267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Dynamics of the Gut Microbiome in Multiple Sclerosis in Relation to Disease.
    Mowry EM; Glenn JD
    Neurol Clin; 2018 Feb; 36(1):185-196. PubMed ID: 29157399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut environmental factors and multiple sclerosis.
    Miyake S; Yamamura T
    J Neuroimmunol; 2019 Apr; 329():20-23. PubMed ID: 30077395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut commensals, dysbiosis, and immune response imbalance in the pathogenesis of multiple sclerosis.
    Brown J; Quattrochi B; Everett C; Hong BY; Cervantes J
    Mult Scler; 2021 May; 27(6):807-811. PubMed ID: 32507072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiome in multiple sclerosis: The players involved and the roles they play.
    Shahi SK; Freedman SN; Mangalam AK
    Gut Microbes; 2017 Nov; 8(6):607-615. PubMed ID: 28696139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-chain fatty acids and gut microbiota in multiple sclerosis.
    Melbye P; Olsson A; Hansen TH; Søndergaard HB; Bang Oturai A
    Acta Neurol Scand; 2019 Mar; 139(3):208-219. PubMed ID: 30427062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis.
    Colpitts SL; Kasper EJ; Keever A; Liljenberg C; Kirby T; Magori K; Kasper LH; Ochoa-Repáraz J
    Gut Microbes; 2017 Nov; 8(6):561-573. PubMed ID: 28708466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
    Parodi B; Kerlero de Rosbo N
    Front Immunol; 2021; 12():718220. PubMed ID: 34621267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiome and multiple sclerosis: New insights and perspective.
    Esmaeil Amini M; Shomali N; Bakhshi A; Rezaei S; Hemmatzadeh M; Hosseinzadeh R; Eslami S; Babaie F; Aslani S; Torkamandi S; Mohammadi H
    Int Immunopharmacol; 2020 Nov; 88():107024. PubMed ID: 33182024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selected Clostridia Strains from The Human Microbiota and their Metabolite, Butyrate, Improve Experimental Autoimmune Encephalomyelitis.
    Calvo-Barreiro L; Eixarch H; Cornejo T; Costa C; Castillo M; Mestre L; Guaza C; Martínez-Cuesta MDC; Tanoue T; Honda K; González-López JJ; Montalban X; Espejo C
    Neurotherapeutics; 2021 Apr; 18(2):920-937. PubMed ID: 33829410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy.
    Yadav SK; Ito K; Dhib-Jalbut S
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxymatrine ameliorates experimental autoimmune encephalomyelitis by rebalancing the homeostasis of gut microbiota and reducing blood-brain barrier disruption.
    Zhang ML; Li WX; Wang XY; Wu YL; Chen XF; Zhang H; Yang LQ; Wu CZ; Zhang SQ; Chen YL; Feng KR; Wang B; Niu L; Kong DX; Tang JF
    Front Cell Infect Microbiol; 2022; 12():1095053. PubMed ID: 36710971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feeding the gut microbiome: impact on multiple sclerosis.
    Bronzini M; Maglione A; Rosso R; Matta M; Masuzzo F; Rolla S; Clerico M
    Front Immunol; 2023; 14():1176016. PubMed ID: 37304278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut dysbiosis and multiple sclerosis.
    Noto D; Miyake S
    Clin Immunol; 2022 Feb; 235():108380. PubMed ID: 32169440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice.
    Berer K; Gerdes LA; Cekanaviciute E; Jia X; Xiao L; Xia Z; Liu C; Klotz L; Stauffer U; Baranzini SE; Kümpfel T; Hohlfeld R; Krishnamoorthy G; Wekerle H
    Proc Natl Acad Sci U S A; 2017 Oct; 114(40):10719-10724. PubMed ID: 28893994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters.
    Miyake S; Kim S; Suda W; Oshima K; Nakamura M; Matsuoka T; Chihara N; Tomita A; Sato W; Kim SW; Morita H; Hattori M; Yamamura T
    PLoS One; 2015; 10(9):e0137429. PubMed ID: 26367776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis.
    Freedman SN; Shahi SK; Mangalam AK
    Neurotherapeutics; 2018 Jan; 15(1):109-125. PubMed ID: 29204955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.